Kalobios Pharmaceuticals Inc (KBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KBIO | TEVA | BBIO | RDY | SUPN |
| Company | Kalobios Pharmaceuticals Inc | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.6500 | 31.95 | 79.28 | 13.18 | 51.23 |
| High | 2.2000 | 32.86 | 79.31 | 13.27 | 52.10 |
| Low | 1.6200 | 31.92 | 76.82 | 13.17 | 50.61 |
| Latest | 2.1900 | 32.60 | 78.00 | 13.27 | 52.03 |
| Change | +0.4630 | +0.13 | -1.11 | +0.05 | +0.58 |
| % Change | +26.81% | +0.40% | -1.40% | +0.38% | +1.13% |
| Volume | 29,900 | 6,047,596 | 1,068,362 | 741,137 | 504,105 |
| 20-Day Average Volume | 12,700 | 8,855,777 | 2,165,594 | 1,121,980 | 624,382 |
| Previous Close | 1.7270 | 32.47 | 79.11 | 13.22 | 51.45 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7043 | 31.51 | 75.92 | 13.84 | 50.58 |
| 20-Day Raw Stochastic | 98.57% | 77.79% | 78.50% | 9.83% | 89.72% |
| 20-Day Relative Strength | 60.40 | 72.68 | 60.65 | 36.47 | 62.16 |
| Weighted Alpha | -53.96 | +87.53 | +147.62 | -11.36 | +48.47 |
| Today's Opinion | N/A | 100% Buy | 100% Buy | 100% Sell | 100% Buy |
| Previous Opinion | N/A | 100% Buy | 100% Buy | 88% Sell | 100% Buy |
| Last Month's Opinion | N/A | 100% Buy | 100% Buy | 56% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +36.88% since 07/28/17 | +0.69% since 01/07/26 | +4.97% since 01/07/26 | -3.03% since 01/07/26 | +1.40% since 01/07/26 |
| Low | 1.5700 on 08/02/17 | 31.80 on 01/09/26 | 70.95 on 01/12/26 | 13.15 on 01/13/26 | 49.40 on 01/13/26 |
| High | 2.2000 on 08/04/17 | 33.42 on 01/12/26 | 79.88 on 01/13/26 | 13.60 on 01/08/26 | 52.50 on 01/12/26 |
| 1-Month | |||||
| %Chg | +12.31% since 07/03/17 | +9.52% since 12/12/25 | +3.74% since 12/12/25 | -5.39% since 12/12/25 | +10.17% since 12/12/25 |
| Low | 1.5000 on 07/11/17 | 29.70 on 12/15/25 | 70.95 on 01/12/26 | 13.15 on 01/13/26 | 46.76 on 12/15/25 |
| High | 2.2000 on 08/04/17 | 33.42 on 01/12/26 | 79.88 on 01/13/26 | 14.32 on 12/23/25 | 52.50 on 01/12/26 |
| 3-Month | |||||
| %Chg | -5.60% since 05/04/17 | +62.23% since 10/14/25 | +37.98% since 10/14/25 | -5.05% since 10/14/25 | +5.56% since 10/14/25 |
| Low | 1.5000 on 07/11/17 | 18.83 on 10/22/25 | 52.75 on 10/23/25 | 13.14 on 10/29/25 | 43.11 on 11/05/25 |
| High | 2.9500 on 05/17/17 | 33.42 on 01/12/26 | 79.88 on 01/13/26 | 14.95 on 10/22/25 | 57.65 on 10/30/25 |
| 6-Month | |||||
| %Chg | -28.20% since 02/03/17 | +98.69% since 07/14/25 | +63.47% since 07/14/25 | -8.89% since 07/14/25 | +52.99% since 07/14/25 |
| Low | 1.5000 on 07/11/17 | 14.99 on 08/01/25 | 42.09 on 08/06/25 | 13.14 on 10/29/25 | 32.20 on 07/18/25 |
| High | 3.2500 on 02/17/17 | 33.42 on 01/12/26 | 79.88 on 01/13/26 | 15.06 on 09/17/25 | 57.65 on 10/30/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,806 | 37,241,792 | 15,245,208 | 11,037,880 | 2,950,092 |
| Shares Outstanding, K | 14,980 | 1,146,960 | 192,709 | 834,938 | 57,339 |
| Annual Sales | 0 | 16,544,000,000 | 221,900,000 | 3,811,000,000 | 661,820,000 |
| Annual Net Income | -27,010,000 | -1,639,000,000 | -535,760,000 | 663,000,000 | 73,870,000 |
| Last Quarter Sales | N/A | 4,480,000,000 | 120,700,000 | 1,012,590,000 | 192,100,000 |
| Last Quarter Net Income | N/A | 433,000,000 | -182,740,000 | 165,280,000 | -45,120,000 |
| 60-Month Beta | 2.99 | 0.66 | 1.17 | 0.37 | 0.67 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.78 on 11/05/25 | -0.95 on 10/29/25 | 0.19 on 10/24/25 | 1.01 on 11/04/25 |
| Latest Earnings Date | 09/22/17 | 01/28/26 | 02/19/26 | 01/22/26 | 02/24/26 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | N/A |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/25/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 12.71 | 0.00 | 16.64 | 24.11 |